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Adoptive immunotherapy with ex vivo-modified T cells shows immense promise as an emerging strategy for 
patients with advanced malignancies. Although promising, most current methods for expansion of gene-modified 
T cells ex vivo are complicated and labor intensive, limiting the broad application of adoptive immunotherapy in 
the future. Traditional T cell expansion protocols are marked by flaws in consistency, safety, the frequency of 
human intervention required, and the length of the manufacturing process. These expansion protocols have 
traditionally involved the use human serum, which is characterized by batch inconsistency, and can potentially 
expose the patient to adverse viral contamination. Moreover, the duration of the expansion phase has typically 
been 10-12 days and involves extensive hands-on operation, while an ideal process would be significantly 
shorter and require minimal cellular disturbance. For the purpose of safety and consistency, serum-free T cell 
expansion media have been developed, and to minimize complexity of the manufacturing process, many 
researchers in the field are turning to the Gas Permeable Rapid Expansion (G-Rex) culture platform, which has 
shown superior cell output and a reduction in the number of required technician manipulations compared to 
conventional approaches. However, to date, there is a dearth of knowledge regarding the use of serum-free 
media in G-Rex systems. To this end, we tested several commercially available serum-free media to see how 
effectively they could expand human T cells in the G-Rex culture system. The results demonstrated that none of 
the serum-free media consistently performed as well as conventional methods that employ serum-containing 
culture media. However, when we further supplemented the best performer from this cohort of serum-free media 
with 4mM GlutaMAX™ and 2% of a chemically defined serum replacement, this medium supported ample T cell 
expansion, with yields similar to or better than media containing human serum. Furthermore, the resultant cell 
population displayed a higher frequency of the desirable central memory phenotype than the cells grown in 
serum-containing media and was indistinguishable from the serum-grown population with regards to both 
CD8/CD4 ratio and functionality. We conclude that combining serum-free media with the G-Rex culture platform 
can be effective for human T cell expansion and that applying this cell culture strategy to the production of T cell 
therapies could potentially address some of the concerns associated with traditional protocols by ensuring 
safety and consistency, shortening the expansion phase, and reducing the excessive amount of technical 
intervention required.    
 
 
